Russia is set to register world’s first coronavirus vaccine on August 12. The inoculation has been developed jointly by the Gamaleya Research Institute and the Russian Defence Ministry.
However, the clinical trial data and other documents of Russia’s COVID-19 vaccine are currently under expert review. The decision on registration will be made based on its results, according to the Russian health ministry.
“The documents that are needed to register the vaccine developed by the Gamaleya Research Institute of the Health Ministry, including clinical trial data, are under expert review. The decision on registration will be made based on the results of the review,” the ministry said.
Russia’s Deputy Health Minister Oleg Gridnev told state news agency, Sputnik news that the Phase-3 clinical trial of the COVID-19 vaccine was underway. He also said that senior citizens and medical professionals will be the first to get vaccinated.
The clinical trial of the Russian coronavirus vaccine is undergoing at two institutions: the Burdenko Main Military Clinical Hospital and the Sechenov First Moscow State Medical University. The clinical trials of the vaccine began on June 18 and included 38 volunteers. All of the participants developed immunity. The first group was discharged on July 15, and the secondon July 20.
How Russia’s coronavirus vaccine will work?
Alexander Gintsburg, director of the Gamaleya National Research Centre, said the vaccine used inanimate particles created on the basis of adenovirus. He added that the vaccine would cause no harm to a person’s health.